Two central nervous system disorder biotechs laid off employees recently.
New York gene therapy startup Apertura and Boston RNAi biotech Atalanta Therapeutics have trimmed their …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.